Professor in Medicine-Cardiology and Surgery-Organ Transplantation, Northwestern University Medical School
Cardiology
Dr. Mihai Gheorghiade, MD
|
|
Give Review
Mihai Gheorghiade, MD is an expert in the field of Cardiology. He received awards:"Meaningful Use Stage 1 Certification", "Fellow (FACC)" and "Super Doctor". Dr. Mihai Gheorghiade is also published. He has 99 publications published. The lastest publication: "Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure.'
Publications
- Contrasting Acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trial.
- Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial).
- Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions.
- Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure.
- Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy: Possible Modulating Effects of Paracrine Activities of Stem Cells.
- Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fract...
- Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic Hypertensive and diabetic patients in primary care: impact of age and gender : Results from...
- In-hospital worsening Heart failure.
- Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials.
- The vulnerable phase after hospitalization for Heart failure.
- Changes in Serum Potassium Levels During Hospitalization in Patients With Worsening Heart Failure and Reduced Ejection Fraction (from the EVEREST Trial).
- Population Risk Prediction Models for Incident Heart Failure: A Systematic Review.
- Digoxin use in Atrial fibrillation: a critical reappraisal.
- Site selection for Heart failure clinical trials in the USA.
- Impact of diabetes on epidemiology, treatment, and outcomes of patients with Heart failure.
- Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients w...
- Resting Heart rate and risk of incident Heart failure: three prospective cohort studies and a systematic meta-analysis.
- Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening Chronic heart failure: findings from the ASTRONA...
- The impact of Coronary artery disease on outcomes after liver transplantation.
- Phenomapping for Novel Classification of Heart Failure with Preserved Ejection Fraction.
- Left atrium in Heart failure with preserved ejection fraction: structure, function, and significance.
- Matching mechanism of death with mechanism of action: considerations for drug development for hospitalized Heart failure.
- Global Perspectives in Hospitalized Heart Failure: Regional and Ethnic Variation in Patient Characteristics, Management, and Outcomes.
- Relation of Serum Uric Acid Levels and Outcomes Among Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressi...
- Mineralocorticoid Receptor Antagonist Use in Hospitalized Patients With Heart Failure, Reduced Ejection Fraction, and Diabetes Mellitus (from the EVEREST Trial).
- A roadmap to inpatient Heart failure management.
- Epidemiology, pathophysiology, and in-hospital management of pulmonary edema: data from the Romanian Acute Heart Failure Syndromes registry.
- Recognizing worsening Chronic heart failure as an entity and an end point in clinical trials.
- Molecular and cellular basis of viable dysfunctional myocardium.
- Geographic variation in Heart failure trials: time for scepticism?
- Hemoconcentration-Guided Diuresis in Heart Failure.
- Management of comorbid diabetes mellitus and worsening Heart failure.
- The burden of Acute heart failure on u.s. Emergency departments.
- Patterns of intensive care unit admissions in patients hospitalized for Heart failure: insights from the RO-AHFS registry.
- Developing Therapies for Heart Failure With Preserved Ejection Fraction: Current State and Future Directions.
- Therapeutic Targets in Heart Failure: Refocusing on the Myocardial Interstitium.
- Beta-blockers in older patients with Heart failure and preserved ejection fraction: Class, dosage, and outcomes.
- Decongestion in Acute heart failure.
- Strategies to reduce Heart failure readmissions--reply.
- Site selection in global clinical trials in patients hospitalized for Heart failure: perceived problems and potential solutions.
- The Use of Digoxin in Patients with Worsening Chronic Heart Failure Reconsidering an Old Drug to Reduce Hospital Admissions.
- Lipids, statins, and clinical outcomes in Heart failure: rethinking the data.
- The Global Health and Economic Burden of Hospitalizations for Heart Failure: Lessons Learned from HHF Registries.
- The Prognostic Significance of Heart Rate in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in Sinus Rhythm: Insights From the EVEREST (Efficac...
- Efficacy and Clinical Effectiveness of Digoxin in Reducing Hospital Admission and Readmission in Patients with Heart Failure and Reduced Ejection Fraction.
- The immunological axis in Heart failure: importance of the leukocyte differential.
- Anticoagulation in Heart failure: current status and future direction.
- Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for Acute heart failure: analysis from th...
- Need for increased awareness and evidence-based therapies for patients hospitalized for Heart failure.
- Relation of Serum Magnesium Levels and Postdischarge Outcomes in Patients Hospitalized for Heart Failure (from the EVEREST Trial).
- Clinical outcome endpoints in Heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.
- The past, present and future of renin-angiotensin aldosterone system inhibition.
- Performance Matters In Heart Failure.
- Progress or lack of progress in hospitalized Heart failure.
- Drug Therapy to Reduce Early Readmission Risk in Heart Failure: Ready for Prime Time?
- Expanding the scope of the "polypill" to Heart failure.
- Heart rate: a prognostic factor and therapeutic target in Chronic heart failure. The distinct roles of drugs with heart rate-lowering properties.
- Hospitalizations for Heart failure. Preface.
- The potential role of nonpharmacologic electrophysiology-based interventions in improving outcomes in patients hospitalized for Heart failure.
- Recognizing hospitalized Heart failure as an entity and developing new therapies to improve outcomes: academics', clinicians', industry's, regulators', and payers' per...
- Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for Heart failure with reduced ejection fraction: insights from the EVEREST...
- Association of low body temperature and poor outcomes in patients admitted with worsening Heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart ...
- Nitrate Therapy for Heart Failure: Benefits and Strategies to Overcome Tolerance.
- The predictive value of transaminases at admission in patients hospitalized for Heart failure: findings from the RO-AHFS registry.
- The role of the emergency department in Acute heart failure clinical trials--enriching patient identification and enrollment.
- Seeking new heights in Acute heart failure syndromes: lessons from ASCEND and EVEREST.
- Return of digoxin and recovery of renal function.
- Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with Chronic heart failure and mild or moderate chroni...
- Evaluative Framework for Phase II Studies in Patients With Heart Failure and Preserved Ejection Fraction.
- Reply - Weighing in on Congestion.
- Lack of evidence of increased mortality among patients with Atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
- Critical reappraisal of pulmonary artery catheterization and invasive hemodynamic assessment in Acute heart failure.
- Strategies and opportunities for drug development in Heart failure.
- Angiotensin-converting Enzyme Inhibitors and Outcomes in Heart Failure and Preserved Ejection Fraction.
- Effect of aliskiren on postdischarge mortality and Heart failure readmissions among patients hospitalized for Heart failure: the ASTRONAUT randomized trial.
- Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in Heart failure with reduced ejection fraction.
- Soluble guanylate cyclase: a potential therapeutic target for Heart failure.
- Current management and future directions for the treatment of patients hospitalized for Heart failure with low blood pressure.
- Ace inhibitor therapy for Heart failure in patients with impaired renal function: a review of the literature.
- Digoxin Reduces 30-day All-cause Hospital Admission in Older Patients with Chronic Systolic Heart Failure.
- Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for Heart failure with reduced ejection fraction: insights from the Effic...
- Aldosterone Antagonists and Outcomes in Real-World Older Patients with Heart Failure and Preserved Ejection Fraction.
- Factors Associated with Improvement in Utilization of Cardiac Resynchronization Therapy in Eligible Heart Failure Patients: Findings from IMPROVE HF.
- The disconnect between phase II and phase III trials of drugs for Heart failure.
- Relationship Between Clinical Trial Site Enrollment With Participant Characteristics, Protocol Completion, and Outcomes: Insights From the EVEREST (Efficacy of Vasopre...
- Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine.
- Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with Heart failure: findings from the EVEREST trial.
- Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for pati...
- Effect of oral digoxin in high-risk Heart failure patients: a pre-specified subgroup analysis of the DIG trial.
- Thirty-day readmissions: the clock is ticking.
- Is thrombosis a contributor to Heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges.
- Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of Heart failure with reduced ejection ...
- Is hospital admission for Heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization.
- Influence of documented history of Coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST t...
- Prognostic Significance of Serum Total Cholesterol and Triglyceride Levels in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST ...
- Rehospitalization for Heart failure: problems and perspectives.
- Mitochondria as a Therapeutic Target in Heart Failure.
- Gender Does Not Affect Postdischarge Outcomes in Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressin Ant...
Schools
Universita Campus BioMedico Di Roma Facolta Di Medicina E Chirurgia
Miriam Hospital
Brown University Hospital
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Health and Life PPO
- Platinum PPO
- First Health (Coventry Health Care) PPO
- HealthLink PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- Meaningful Use Stage 1 Certification
- Fellow (FACC)
- Super Doctor
Education
-
Sapienza University of Rome
Hospital
-
Northwestern Memorial Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Mark D. Huffman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark T. Upton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francis Alenghat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark J. Ricciardi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley J. Heller, MD |
|
|
Dr. David Lieb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judith L. Meadows, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amit Vyas, MD |
|
Dr. Raja K. Mutharasan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tariq M. Malik, MD |
|
|
Dr. Marwan Dib, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph D. Campbell, MD |
|
|
Dr. Bryan A. Smith, MD |